Revision history of "Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis)." (Q34544500)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

9 January 2024

26 May 2022

27 March 2022

30 November 2020

19 August 2020

22 July 2020

12 May 2020

25 September 2019

15 June 2019

24 April 2019

11 April 2019

3 October 2018

7 September 2018

9 October 2017

  • curprev 12:5612:56, 9 October 2017 Emijrpbot talk contribs 30,729 bytes +4,693 Updated Item: BOT - Adding descriptions (57 languages): ar, ast, bg, bn, ca, cs, da, de, el, eo, es, et, fi, fr, gl, he, hu, hy, it, ja, ka, ko, lt, nan, nb, nl, nn, oc, pl, pt, pt-br, ro, ru, sk, sq, sr, sr-ec, sr-el, sv, tg, tg-cy... undo (restore)

2 August 2017